rizatriptan 10 MG Disintegrating Oral Tablet
1 INDICATIONS AND USAGE Rizatriptan benzoate orally disintegrating tablets are indicated for the acute treatment of migraine with or without aura in adults and in pediatric patients 6 to 17 years old. Limitations of Use • Rizatriptan benzoate orally disintegrating tablets should only be used where a clear diagnosis of migraine has been established. If a patient has no response for the first migraine attack treated with rizatriptan benzoate orally disintegrating tablets, the diagnosis of migraine should be reconsidered before rizatriptan benzoate orally disintegrating tablets are administered to treat any subsequent attacks. • Rizatriptan benzoate orally disintegrating tablets are not indicated for use in the management of hemiplegic or basilar migraine [see Contraindications ( 4 )]. • Rizatriptan benzoate orally disintegrating tablets are not indicated for the prevention of migraine attacks. • Safety and effectiveness of rizatriptan benzoate orally disintegrating tablets have not been established for cluster headache. Rizatriptan benzoate is a serotonin (5-HT) 1B/1D receptor agonist (triptan) indicated for the acute treatment of migraine with or without aura in adults and in pediatric patients 6 to 17 years of age ( 1 ) Limitations of Use: • Use only after clear diagnosis of migraine has been established ( 1 ) • Not indicated for the prophylactic therapy of migraine ( 1 ) • Not indicated for the treatment of cluster headache ( 1 )
glenmark pharmaceuticals inc., usa
ROUND WHITE 468
Related Pills
rizatriptan 5 MG Disintegrating Oral Tablet
glenmark pharmaceuticals inc., usa
propranolol hydrochloride tablet
teva pharmaceuticals usa, inc.
Diphenhydramine Hydrochloride 50 MG Oral Tablet Somnapure
NutraClick, LLC
Diphenhydramine Hydrochloride 50 MG Oral Tablet Somnapure
NutraClick, LLC
Propranolol Hydrochloride 20 MG Oral Tablet
a-s medication solutions
DISCLAIMER:
"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."
"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."
"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."
PillSync may earn a commission via links on our site
16 HOW SUPPLIED/STORAGE AND HANDLING
RIZATRIPtan BENZOATE orally disintegrating tablets, USP 5 mg (equivalent to 7.265 mg
RIZATRIPtan BENZOATE) are white to off‑white, round, flat beveled edged, uncoated orally disintegrating tablets engraved with ‘467’ on one side and plain on the other side with a peppermint flavor. They are supplied as follows: Carton of 12 (2 x 6 unit-dose), NDC 68462-467-74 Carton of 18 (3 x 6 unit-dose), NDC 68462-467-06
RIZATRIPtan BENZOATE orally disintegrating tablets, USP 10 mg (equivalent to 14.53 mg
RIZATRIPtan BENZOATE) are white to off‑white, round, flat beveled edged, uncoated orally disintegrating tablets engraved with ‘468’ on one side and plain on the other side with a peppermint flavor. They are supplied as follows: Carton of 12 (2 x 6 unit-dose), NDC 68462-468-74 Carton of 18 (3 x 6 unit-dose), NDC 68462-468-06 Storage Store at 20°C to 25°C (68°F to 77°F); excursions permitted to 15°C to 30°C (59°F to 86°F) [see USP Controlled Room Temperature]. Dispense in a tight, light-resistant container as defined in the USP using a child-resistant closure.
More pills like ROUND 468